Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter March 13, 2009

The knockdown of c-myc expression by RNAi inhibits cell proliferation in human colon cancer HT-29 cells in vitro and in vivo

  • Xiao Zhang EMAIL logo , Yin-Lin Ge and Run-Hua Tian

Abstract

We investigated the effects of RNA interference-mediated silencing of the c-myc gene on celluar proliferation and apoptosis in human colon cancer HT-29 cells in vitro and in vivo. A small interfering RNA (siRNA) targeting c-myc was designed, the DNA template was synthesized, and the siRNA was obtained by in vitro transcription. After siRNA transfection into HT-29 and human neuroblastoma IMR-32 cells with Lipofectamine 2000™, the proliferation of the HT-29 and IMR-32 cells was assessed via 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) colorimetry, and Hoechst 33258 staining was used to observe cell apoptosis. Following gene transfer to HT-29 cells, the expression of c-myc mRNA was examined via reverse transcription polymerase chain reaction, and the level of the protein via Western blot assay. Growth curves were constructed and in vivo experiments were performed on nude mice to assess the effects of c-myc silencing on tumor growth. The c-myc expression in the tumor tissue was measured by reverse transcription polymerase chain reaction and subsequently by immunohistochemistry. Our paper demonstrates that the delivery of siRNA directed against c-myc not only efficiently down-regulated the expression of c-myc, inhibited the proliferation of HT-29 cells and induced apoptosis in vitro, but also suppressed the growth of colon cancer cells in vivo.

[1] Ahmed, F.E. Molecular markers that predict response to colon cancer therapy. Expert Rev. Mol. Diagn. 5 (2005) 353–375. http://dx.doi.org/10.1586/14737159.5.3.35310.1586/14737159.5.3.353Search in Google Scholar PubMed

[2] Grady, W.M. and Carethers, J.M. Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis. Gastroenterology 135 (2008) 1079–1099. http://dx.doi.org/10.1053/j.gastro.2008.07.07610.1053/j.gastro.2008.07.076Search in Google Scholar PubMed PubMed Central

[3] Grandori, C., Cowley, S.M., James, L.P. and Eisenman, R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16 (2000) 653–699. http://dx.doi.org/10.1146/annurev.cellbio.16.1.65310.1146/annurev.cellbio.16.1.653Search in Google Scholar PubMed

[4] Bondi, J., Bukholm, G., Nesland, J.M. and Bukholm, I.R. Expression of non-membranous beta-catenin and gamma-catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas. APMIS 112 (2004) 49–56. http://dx.doi.org/10.1111/j.1600-0463.2004.apm1120109.x10.1111/j.1600-0463.2004.apm1120109.xSearch in Google Scholar PubMed

[5] Csontos, Z., Nádasi, E., Csejtey, A., Illényi, L., Kassai, M., Lukács, L., Kelemen, D., Kvarda, A. Zólyomi, A., Horváth, O.P. and Ember, I. Oncogene and tumor suppressor gene expression changes in the peripheral blood leukocytes of patients with colorectal cancer. Tumori 94 (2008) 79–82. Search in Google Scholar

[6] Dang, C.V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19 (1999) 1–11. 10.1128/MCB.19.1.1Search in Google Scholar PubMed PubMed Central

[7] Hongxing, Z., Nancai, Y., Wen, S., Guofu, H., Yanxia, W., Hanju, H., Qian, L., Wei, M., Yandong, Y. and Hao, H. Depletion of c-Myc inhibits human colon cancer colo 320 cells’ growth. Cancer Biother. Radiopharm. 23 (2008) 229–237. http://dx.doi.org/10.1089/cbr.2007.044110.1089/cbr.2007.0441Search in Google Scholar PubMed

[8] Schwab, M., Reynders, V., Loitsch, S., Shastri, Y.M., Steinhilber, D., Schröder, O. and Stein, J. PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells. Carcinogenesis 29 (2008) 1407–1414. http://dx.doi.org/10.1093/carcin/bgn11810.1093/carcin/bgn118Search in Google Scholar PubMed

[9] Wilkins, J.A. and Sansom, O.J. C-Myc is a critical mediator of the phenotypes of Apc loss in the intestine. Cancer Res. 68 (2008) 4963–4966. http://dx.doi.org/10.1158/0008-5472.CAN-07-555810.1158/0008-5472.CAN-07-5558Search in Google Scholar PubMed

[10] Colnot, S., Niwa-Kawakita, M., Hamard, G., Godard, C., Le Plenier, S., Houbron, C., Romagnolo, B., Berrebi, D., Giovannini, M. and Perret, C. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab. Invest. 84 (2004) 1619–1630. http://dx.doi.org/10.1038/labinvest.370018010.1038/labinvest.3700180Search in Google Scholar PubMed

[11] Al-Kuraya, K., Novotny, H., Bavi, P., Siraj, A.K., Uddin, S., Ezzat, A., Sanea, N.A., Al-Dayel, F., Al-Mana, H., Sheikh, S.S., Mirlacher, M., Tapia, C., Simon, R., Sauter, G., Terracciano, L. and Tornillo, L. HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer. J. Clin. Pathol. 60 (2007) 768–772. http://dx.doi.org/10.1136/jcp.2006.03828110.1136/jcp.2006.038281Search in Google Scholar PubMed PubMed Central

[12] Stewart, J., Evan, G., Watson, J. and Sikora, K. Detection of the c-myc oncogene product in colonic polyps and carcinomas. Br. J. Cancer 53 (1986) 1–6. Search in Google Scholar

[13] Hannon, G.J. RNA interference. Nature 418 (2002) 244–251. http://dx.doi.org/10.1038/418244a10.1038/418244aSearch in Google Scholar

[14] Watson, P.H., Pon, R.T. and Shiu, R.P.C. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Cancer Res. 51 (1991) 3996–4000. Search in Google Scholar

[15] Hong, J., Zhao, Y. and Huang, W. Blocking c-myc and stat3 by E. coli expressed and enzyme digested siRNA in mouse melanoma. Biochem. Biophys. Res. Commun. 348 (2006) 600–605. http://dx.doi.org/10.1016/j.bbrc.2006.07.10710.1016/j.bbrc.2006.07.107Search in Google Scholar

[16] Liao, D.J. and Dickson, R.B. c-Myc in breast cancer. Endocr. Relat. Cancer 7 (2000) 143–164. http://dx.doi.org/10.1677/erc.0.007014310.1677/erc.0.0070143Search in Google Scholar

[17] Kruszewski, W., Kowara, R., Rzepko, R., Warezak, C., Zieliński, J., Gryglewski, G., Kopacz, A., Jastrzebski, T. and Pawełczyk, T. K-RAS point mutation, and amplification of C-MYC and C-ERBB2 in colon adenocarcinoma. Folia Histochem. Cytobiol. 42 (2004) 173–179. Search in Google Scholar

[18] Nagy, B., Szendroi, A. and Romics, I. Overexpression of CD24, c-myc and Phospholipase 2A in prostate cancer tissue samples obtained by needle biopsy. Pathol. Oncol. Res. 2008. 10.1007/s12253-008-9077-1Search in Google Scholar

[19] Steiner, M.S., Anthony, C.T., Lu, Y. and Holt, J.T. Antisense c-myc retroviral vector suppresses established human prostate cancer. Hum. Gene Ther. 9 (1998) 747–755. http://dx.doi.org/10.1089/hum.1998.9.5-74710.1089/hum.1998.9.5-747Search in Google Scholar

[20] Bressin, C., Bourgarel-Rey, V., Carré, M., Pourroy, B., Arango, D., Braguer, D. and Barra, Y. Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine. Anticancer Drugs 17 (2006) 181–187. http://dx.doi.org/10.1097/00001813-200602000-0000910.1097/00001813-200602000-00009Search in Google Scholar

[21] Zhao, H.Y., Ooyama, A., Yamamoto, M., Ikeda, R., Haraguchi, M., Tabata, S., Furukawa, T., Che, X.F., Iwashita, K.I., Oka, T., Fukushima, M., Nakagawa, M., Ono, M., Kuwano, M. and Akiyama, S.I. Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells. Cancer Lett. 270 (2008) 156–163. http://dx.doi.org/10.1016/j.canlet.2008.04.04510.1016/j.canlet.2008.04.045Search in Google Scholar

[22] Bertrand, J.R., Pottier, M., Vekris, A., Opolon, P., Maksimenko, A. and Malvy, C. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem. Biophys. Res. Commun. 296 (2002) 1000–1004. http://dx.doi.org/10.1016/S0006-291X(02)02013-210.1016/S0006-291X(02)02013-2Search in Google Scholar

[23] Prendergast, G.C. Mechanisms of apoptosis by c-Myc. Oncogene 1 (1999) 2967–2987. http://dx.doi.org/10.1038/sj.onc.120272710.1038/sj.onc.1202727Search in Google Scholar PubMed

[24] Wang, Y.H., Liu, S., Zhang, G., Zhou, C.Q., Zhu, H.X., Zhou, X.B., Quan, L.P., Bai, J.F. and Xu, N.Z. Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res. 7 (2005) 220–228. http://dx.doi.org/10.1186/bcr97510.1186/bcr975Search in Google Scholar PubMed PubMed Central

Published Online: 2009-3-13
Published in Print: 2009-6-1

© 2009 University of Wrocław, Poland

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 19.3.2024 from https://www.degruyter.com/document/doi/10.2478/s11658-009-0001-9/html
Scroll to top button